NeoStem completes direct public offering

NeoStem Inc. (NYSE-A:NBS), New York, N.Y. Business: Gene/Cell therapy, Supply/Service Date completed: 11/19/10 Type: Direct public offering Raised: $10.1 million Units: 10.6 million Price: $0.95 (unit...